The Effect of Oxytocin on Gastric Emptying
NCT01152047 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2015-04-07
Summary
The investigators have seen that oxytocin lowers satiety in healthy subjects. Patients with dyspepsia suffers from decreased accommodation and increased satiety postprandially. The investigators now want to examine whether oxytocin may diminish symptoms in these patients.
Conditions
- Dyspepsia
- Lack of Satiety
Interventions
- DRUG
-
oxytocin
40mU/min as infusion of oxytocin
Sponsors & Collaborators
-
Skane University Hospital
lead OTHER
Principal Investigators
-
Bodil Ohlsson, professor · Divsion of Internal Medicine
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2015-04-30
- Completion
- 2015-04-30
Countries
- Sweden
Study Locations
More Related Trials
-
Domperidone for Chronic Nausea and Vomiting
NCT02757534 ·Status: NO_LONGER_AVAILABLE
-
Oral Ondansetron to Improve Patient Experience of Unsedated Esophagogastroduodenoscopy Pilot Study
NCT07264738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
NCT03297021 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance
NCT01039805 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Implications of Acutaping on Nausea and Vomiting During Pregnancy
NCT06259747 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040
NCT00562848 ·Status: COMPLETED ·Phase: PHASE1
-
Ondansetron Combined with Dyclonine Hydrochloride to Improve Patient Experience in Unsedated Esophagogastro-duodenoscopy
NCT06729307 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effects of Oxybutynin Topical Gel on Gastric Emptying
NCT00926926 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Dexmedetomidine on Gastric Emptying and Gastrointestinal Transit
NCT01084473 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
NCT05832151 ·Status: COMPLETED ·Phase: PHASE2
-
Autonomic Reactivity and Personalized Neurostimulation
NCT06863207 ·Status: RECRUITING ·Phase: NA
-
Metoclopramide vs Placebo for Prevention of Pneumonia in Acute Stroke
NCT04873297 ·Status: COMPLETED ·Phase: PHASE4
-
Opioid Effects on Swallowing and Esophageal Sphincter Pressure
NCT01191645 ·Status: COMPLETED ·Phase: PHASE4
-
Prokinetic Drugs and Enteral Nutrition
NCT00916591 ·Status: UNKNOWN
-
An Economic Study of HSK21542 Injection for Prevention of Postoperative Nausea and Vomiting
NCT06359535 ·Status: RECRUITING ·Phase: PHASE4
-
Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery
NCT06488001 ·Status: RECRUITING ·Phase: PHASE2
-
Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery
NCT01510379 ·Status: COMPLETED ·Phase: NA
-
Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia
NCT06360900 ·Status: RECRUITING ·Phase: NA
-
Effect of Ginger on Nausea and Vomiting During Acute Gastroenteritis in Children
NCT02701491 ·Status: COMPLETED ·Phase: PHASE2
-
To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions
NCT00946387 ·Status: COMPLETED ·Phase: PHASE1
-
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)
NCT00090155 ·Status: COMPLETED ·Phase: PHASE3
-
Naloxegol for Opioid-Related Gastroparesis
NCT03036891 ·Status: WITHDRAWN ·Phase: PHASE2
-
Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)
NCT00981487 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia
NCT03941288 ·Status: COMPLETED ·Phase: PHASE2
-
Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study
NCT01934192 ·Status: TERMINATED ·Phase: PHASE2